Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
about
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro dataEvaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affectDifferences between opioids: pharmacological, experimental, clinical and economical perspectivesClinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentOpioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk managementPharmacokinetic interactions between buprenorphine and antiretroviral medications.Genetic mutations that prevent pain: implications for future pain medication.Pharmacogenetics of analgesics: toward the individualization of prescription.Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review.Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain.Opioids Resistance in Chronic Pain Management.Pharmacogenetics of opioid analgesics in dogs.The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.Rifampicin markedly decreases the exposure to oral and intravenous tramadol.P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
P2860
Q27009128-4B118228-808D-41F8-A76B-E40D07DE6B89Q33838839-9028244A-F148-4405-B359-640DC4FA404CQ34272502-537AAA43-E3BF-4964-B80C-EDB7084EF040Q34608990-7449DFE7-0FAA-47D0-AD8B-314ED8D7A4C3Q36107418-24FD9D0D-1354-496D-BFB9-5C10BC801078Q36392325-61436049-C79E-4D8C-94DC-7FD8CC17F344Q36655057-91A7F7DB-9735-4754-9424-DB538C3F8EE6Q37120834-E47DF9B1-F869-4A74-AF9B-789D42996DD9Q37205954-45DA91D3-5C91-4AF4-AD04-6F6E1589B682Q38247246-712C6AD6-3546-4B03-BEEC-D0BAF8D93966Q38478413-D1AA569D-444D-4C7F-B7EA-E97B1FB4941DQ39285381-AEDEF777-1631-42B0-9029-87E37B20BD32Q39305721-1720174F-0198-4D46-B713-9A8557DDD1CFQ43076078-F4745A31-65AA-4C1C-8B64-B846F752D08FQ43257503-9514837E-1E4C-42C1-99A9-655FBFC464E4Q43663355-22028D5B-DE60-4280-B522-6ECC5F247738Q47988249-E2C64396-8D78-4F1A-8527-149E82879201Q50668713-CF74F4B9-E55C-469B-9CBF-680C13D08775Q51579656-805306FE-04EF-4FA9-AD70-857D9B79B247
P2860
Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@en
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@nl
type
label
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@en
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@nl
prefLabel
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@en
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@nl
P2093
P2860
P356
P1476
Quinidine as a probe for the r ...... clinical effects of fentanyl.
@en
P2093
Christine Hoffer
Dale Whittington
Evan D Kharasch
T Gul Altuntas
P2860
P304
P356
10.1177/0091270003262075
P577
2004-03-01T00:00:00Z